Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Immunology analyses NEC
ADR ID BADD_A02256
ADR Hierarchy
13      Investigations
13.06      Immunology and allergy investigations
13.06.03      Immunology analyses NEC
Description Not Available
MedDRA Code 10021504
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01596Ofatumumab--
BADD_D01610Omalizumab--
BADD_D01620Oprelvekin--
BADD_D01655Palifermin--
BADD_D01666Panitumumab--
BADD_D01673Parathyroid hormone--
BADD_D01692Pegaspargase--
BADD_D01693Pegfilgrastim--
BADD_D01695Peginterferon alfa-2a--
BADD_D01696Peginterferon alfa-2b--
BADD_D01697Peginterferon beta-1a--
BADD_D01699Pegvisomant--
BADD_D01911Ramucirumab--
BADD_D01917Rasburicase--
BADD_D01918Raxibacumab--
BADD_D01939Rilonacept--
BADD_D01953Rituximab--
BADD_D01965Romiplostim--
BADD_D01996Sebelipase alfa--
BADD_D02001Secukinumab--
BADD_D02021Siltuximab--
BADD_D02137Teduglutide--
BADD_D02206Thrombin alfa--
BADD_D02252Tositumomab--
BADD_D02342Vedolizumab--
BADD_D02343Velaglucerase alfa--
The 2th Page    First    Pre   2    Total 2 Pages